The Vanguard Group 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:02 pm Purchase | 2023-12-29 | 13G | Day One Biopharmaceuticals, Inc. DAWN | The Vanguard Group | 4,769,746 5.480% | 4,769,746 (New Position) | Filing |